Since the mid 1980's the pharmaceutical industry was given permission to market their products directly to potential patients. Some believe this has been a important step in educating patients about innovation and options in their care. Others are critical of the impact on cost. According to the attached report "DTC ads fuel demand for expensive brand name drugs among consumers, leading to a significant rise in national drug spending. " Recently the AMA (according to the article) called for the banning of direct to consumer advertising by pharmaceutical companies .
The Direct of Consumer Advertising of pharmaceuticals appears to be only allowable in the USA and New Zealand. I would love to begin a global discussion on the risk and benefits of this practice.
Link leads to: http://www.beckershospitalreview.com/hospital-management-administration/are-drug-ads-undermining-attempts-at-thrifty-healthcare-behavior-8-thoughts.html